Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Ozge Can Bostan, Emine Duran, Gulseren Tuncay, Melek Cihanbeylerden, Omer Karadag, Ebru Damadoglu, Gul Karakaya & Ali F. Kalyoncu. (2023) Sinonasal and respiratory outcomes of eosinophilic granulomatosis with polyangiitis patients receiving 100 mg mepolizumab in real-life clinical practice: 1-year follow up study. Journal of Asthma 60:5, pages 931-937.
Read now
Read now
Mirna Vergles, Zinka Matković, Kristina Lalić, Jasna Tekavec Trkanjec & Neven Tudorić. (2021) Mepolizumab as a glucocorticoid-sparing agent in eosinophilic granulomatosis with polyangiitis (EGPA): is a lower dose sufficient?. Journal of Asthma 58:12, pages 1675-1679.
Read now
Read now
Daniel Ennis, Jason Kihyuk Lee & Christian Pagnoux. (2019) Mepolizumab for the treatment of eosinophilic granulomatosis with
polyangiitis. Expert Opinion on Biological Therapy 19:7, pages 617-630.
Read now
Read now
Articles from other publishers (31)
Takaharu Ikeda, Toshiro Komatsu, Kae Yokoyama & Tamihiro Kawakami. (2023) Earlier continuous administration of mepolizumab for eosinophilic granulomatosis with polyangiitis based on cutaneous findings. Journal of Cutaneous Immunology and Allergy.
Crossref
Crossref
Mari Sato, Masakiyo Yatomi, Ikuo Wakamatsu, Shogo Uno, Chiharu Hanazato, Tomomi Masuda, Koichi Yamaguchi, Haruka Aoki-Saito, Norimitsu Kasahara, Yosuke Miura, Hiroaki Tsurumaki, Kenichiro Hara, Yasuhiko Koga, Noriaki Sunaga, Takuhisa Okada, Hayato Ikota, Takeshi Hisada & Toshitaka Maeno. (2023) Effective treatment with mepolizumab in a patient with severe eosinophilic granulomatosis with polyangiitis complicated with small intestine perforation. Respiratory Medicine Case Reports 43, pages 101818.
Crossref
Crossref
Georgios Tsioulos, Dimitris Kounatidis, Natalia G. Vallianou, Nektarios Koufopoulos, Pelagia Katsimbri & Anastasia Antoniadou. (2023) Severe eosinophilic granulomatosis with polyangiitis responding to a combination of rituximab and mepolizumab. The American Journal of the Medical Sciences 365:1, pages 93-98.
Crossref
Crossref
Giuseppe A. Ramirez, Adriana Cariddi, Silvia Noviello, Corrado Campochiaro, Valentina Canti, Luca Moroni, Mona-Rita Yacoub, Elena M. Baldissera, Enrica P. Bozzolo & Lorenzo Dagna. (2022) Real-life efficacy and safety of mepolizumab for eosinophilic granulomatosis with polyangiitis. Clinical Immunology Communications 2, pages 23-29.
Crossref
Crossref
Megan E. Milne, Jack Kimball, Teresa K. Tarrant, Rami N. Al-Rohil & David L. Leverenz. (2022) The Role of T Helper Type 2 (Th2) Cytokines in the Pathogenesis of Eosinophilic Granulomatosis with Polyangiitis (eGPA): an Illustrative Case and Discussion. Current Allergy and Asthma Reports 22:11, pages 141-150.
Crossref
Crossref
Yasuhiko Koga, Haruka Aoki-Saito, Yosuke Kamide, Makiko Sato, Hiroaki Tsurumaki, Masakiyo Yatomi, Tamotsu Ishizuka & Takeshi Hisada. (2022) Perspectives on the Efficacy of Benralizumab for Treatment of Eosinophilic Granulomatosis With Polyangiitis. Frontiers in Pharmacology 13.
Crossref
Crossref
Alessandra Bettiol, Maria Letizia Urban, Lorenzo Dagna, Vincent Cottin, Franco Franceschini, Stefano Del Giacco, Franco Schiavon, Thomas Neumann, Giuseppe Lopalco, Pavel Novikov, Chiara Baldini, Carlo Lombardi, Alvise Berti, Federico Alberici, Marco Folci, Simone Negrini, Renato Alberto Sinico, Luca Quartuccio, Claudio Lunardi, Paola Parronchi, Frank Moosig, Georgina Espígol‐Frigolé, Jan Schroeder, Anna Luise Kernder, Sara Monti, Ettore Silvagni, Claudia Crimi, Francesco Cinetto, Paolo Fraticelli, Dario Roccatello, Angelo Vacca, Aladdin J. Mohammad, Bernhard Hellmich, Maxime Samson, Elena Bargagli, Jan Willem Cohen Tervaert, Camillo Ribi, Davide Fiori, Federica Bello, Filippo Fagni, Luca Moroni, Giuseppe Alvise Ramirez, Mouhamad Nasser, Chiara Marvisi, Paola Toniati, Davide Firinu, Roberto Padoan, Allyson Egan, Benjamin Seeliger, Florenzo Iannone, Carlo Salvarani, David Jayne, Domenico Prisco, Augusto Vaglio, Giacomo Emmi, Kais Ahmad, Mirko Beccalli, Bernard Bonnotte, Roberto Bortolotti, Adriana Cariddi, Marco Caminati, Maria C Cid, Margherita Deidda, Paolo Delvino, Gerardo Di Scala, Mara Felicetti, Francesco Ferro, Federica Furini, Elena Gelain, Giulia Ghirelli, Julia Holle, Laura Michelina Losappio, Alfred Mahr, Danilo Malandrino, Juliane Marhhold, Irene Mattioli, Laura Moi, Sergey Moiseev, Francesco Muratore, Santi Nolasco, Bianca Olivieri, Adalgisa Palermo, Francesca Regola, Oliver Sander, Riccardo Scarpa, Savino Sciascia, Elena Silvestri, Nicola Susca, Benjamin Terrier, Elena Treppo, Barbara Trezzi, Martina Uzzo, Gianfranco Vitiello & Elaine Yacyshyn. (2021) Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study. Arthritis & Rheumatology 74:2, pages 295-306.
Crossref
Crossref
Kana Higashitani, Ryusuke Yoshimi, Yuichiro Sato, Toshiyuki Watanabe & Atsushi Ihata. (2022) Rituximab and mepolizumab combination therapy for glucocorticoid-resistant myocarditis related to eosinophilic granulomatosis with polyangiitis. Modern Rheumatology Case Reports 6:1, pages 87-92.
Crossref
Crossref
Callum Howard, Jonathan Sheridan, Leonardo Picca, Wahaj Munir, Nehman Meharban, Prassana Karthik, Mohammed Idhrees, Emmanuel Keddy Momoh & Mohammad Bashir. 2022. Translational Autoimmunity. Translational Autoimmunity
189
228
.
Susanne Benseler. 2020. Pädiatrische Rheumatologie. Pädiatrische Rheumatologie
1
14
.
Susanne Benseler. 2022. Pädiatrische Rheumatologie. Pädiatrische Rheumatologie
683
696
.
Yvonne Lee & Mehrnaz Hojjati. (2021) Benralizumab as a Potential Adjunctive Therapy in Eosinophilic Granulomatosis With Polyangiitis. JCR: Journal of Clinical Rheumatology 27:8S, pages S401-S402.
Crossref
Crossref
Chrong-Reen Wang, Yi-Shan Tsai, Hung-Wen Tsai & Cheng-Han Lee. (2021) B-Cell-Depleting Therapy Improves Myocarditis in Seronegative Eosinophilic Granulomatosis with Polyangiitis. Journal of Clinical Medicine 10:19, pages 4577.
Crossref
Crossref
Kelvin Truong, Shane Kelly, Angela Bayly & Annika Smith. (2021) Successful mepolizumab treatment for DRESS-induced refractory eosinophilic myocarditis and concurrent thyroiditis. BMJ Case Reports 14:7, pages e242240.
Crossref
Crossref
Aikaterini Detoraki, Eugenio Tremante, Remo Poto, Emanuela Morelli, Giuseppe Quaremba, Francescopaolo Granata, Antonio Romano, Ilaria Mormile, Francesca Wanda Rossi, Amato de Paulis & Giuseppe Spadaro. (2021) Real-life evidence of low-dose mepolizumab efficacy in EGPA: a case series. Respiratory Research 22:1.
Crossref
Crossref
Misa Kusumoto & Bryan J. Mathis. (2021) Biologic Treatments for Asthma and Chronic Obstructive Pulmonary Disorder. Allergies 1:2, pages 92-107.
Crossref
Crossref
Takaharu Ikeda, Toshiro Komatsu, Kae Yokoyama, Kazuo Takahashi & Tamihiro Kawakami. (2020) Early add‐on administration of mepolizumab and intravenous immunoglobulin effective in treating eosinophilic granulomatosis with polyangiitis. The Journal of Dermatology 48:4, pages 529-532.
Crossref
Crossref
Athanasia Warnecke & Anja Giesemann. (2021) Embryologie, Fehlbildungen und seltene Erkrankungen der
Cochlea. Laryngo-Rhino-Otologie 100:S 01, pages S1-S43.
Crossref
Crossref
Nidaa Rasheed, Rahul Ahuja & Hena Borneo. (2021) Polyangiitis overlap syndrome: a novel presentation of microscopic polyangiitis and eosinophilic granulomatosis with polyangiitis. BMJ Case Reports 14:2, pages e239031.
Crossref
Crossref
Eunsil Koh, Noeul Kang, Jin-Young Lee, Duk-Kyung Kim, Young Soo Do, Byung-Jae Lee & Dong-Chull Choi. (2020) Multiple hepatic aneurysms and dry gangrene of fingertips in eosinophilic granulomatosis with polyangiitis: a case report. Allergy, Asthma & Clinical Immunology 16:1.
Crossref
Crossref
Muhammad Ishaq Ghauri & Muhammad Shariq Mukarram. 2020. Vascular Biology - Selection of Mechanisms and Clinical Applications. Vascular Biology - Selection of Mechanisms and Clinical Applications.
Manato Yasuda, Atsuhiko Sugiyama, Tomoki Suichi, Sonoko Misawa & Satoshi Kuwabara. (2020) Marked neurological and immunological improvement in refractory eosinophilic granulomatous polyangiitis after treatment with mepolizumab, an anti‐interleukin‐5 antibody: A case report. Clinical and Experimental Neuroimmunology 11:3, pages 181-184.
Crossref
Crossref
Yong S. Han, Ashish M. Mehta, Thomas C. Lee, Aaron Nagiel & Jose S. Pulido. (2020) Diagnostic and Therapeutic Challenges. Retina 40:8, pages 1641-1643.
Crossref
Crossref
Angelo Valerio Marzano & Giovanni Genovese. (2020) Eosinophilic Dermatoses: Recognition and Management. American Journal of Clinical Dermatology 21:4, pages 525-539.
Crossref
Crossref
Agura Afiari, Andre Gabriel & Meghana R Gaiki. (2020) Concurrent Use of Mepolizumab and Rituximab for Eosinophilic Granulomatosis With Polyangiitis and Multisystem Involvement. Cureus.
Crossref
Crossref
Carlos Melero Moreno, Marta Corral Blanco & Rocío Magdalena Díaz Campos. 2020. Cells of the Immune System. Cells of the Immune System.
Viviana Alejandra Moyano, Erica Ivana Cuestas, Juan Alejandro Albiero, Rodrigo Ferreyra Dillon, Betiana Lorena Pereyra, Vanesa Estefanía Perrone, Silvana Guendulain, José Ignacio Lugones & Juan Pablo Casas. (2020) Granulomatosis eosinofílica con poliangeítis tratada con mepolizumab en dosis de 100 mg/mes. Archivos de Bronconeumología 56:4, pages 253-254.
Crossref
Crossref
Alejandra Moyano Viviana, Erica Ivana Cuestas, Juan Alejandro Albiero, Rodrigo Ferreyra Dillon, Lorena Pereyra Betiana, Vanesa Estefanía Perrone, Silvana Guendulain, José Ignacio Lugones & Juan Pablo Casas. (2020) Eosinophilic granulomatosis with polyangiitis treated with mepolizumab at a dose of 100 mg/month. Archivos de Bronconeumología (English Edition) 56:4, pages 253-254.
Crossref
Crossref
Angelo Coppola, Krisstopher Richard Flores & Francesca De Filippis. (2020) Rapid onset of effect of benralizumab on respiratory symptoms in a patient with eosinophilic granulomatosis with polyangiitis. Respiratory Medicine Case Reports 30, pages 101050.
Crossref
Crossref
Maureen Rischmueller, Sarah Downie-Doyle & Robert Fitridge. 2020. Mechanisms of Vascular Disease. Mechanisms of Vascular Disease
361
393
.
Ioanna Petta, Isabelle Peene, Dirk Elewaut, Lars Vereecke & Karolien De Bosscher. (2019) Risks and benefits of corticosteroids in arthritic diseases in the clinic. Biochemical Pharmacology 165, pages 112-125.
Crossref
Crossref